Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the Alma System in Treating Abnormal Postpartum utErine Bleeding or Hemorrhage

NCT06646653 is registered in ClinicalTrials.gov with ResQ Medical Ltd as lead sponsor.

NCT NCT06646653
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06646653 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the Alma System in Treating Abnormal Postpartum utErine Bleeding or Hemorrhage
Lead sponsor
ResQ Medical Ltd
Phase
Phase 3
Overall status
Recruiting
Start date
January 11, 2026
Completion date
April 30, 2027
Enrollment
50 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

postpartum haemorrhage (pph), postpartum hemorrhage (primary), pph